The Commission's AstraZeneca decision: delaying generic entry is an abuse of a dominant position |
| |
Authors: | Lawrance, Sophie Treacy, Pat |
| |
Abstract: | The European Commission's recent AstraZeneca decision introducesabuse of the patent system as a novel type of infringement ofArticle 82 EC. |
| |
Keywords: | |
本文献已被 Oxford 等数据库收录! |
|